日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 study

MonumentTAL-1 研究中，Talquetamab 治疗日本复发/难治性多发性骨髓瘤患者

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-025-04134-6
Ito, Shigeki; Kuroda, Yoshiaki; Sunami, Kazutaka; Matsue, Kosei; Imada, Kazunori; Tamura, Hideto; Fujikawa, Ei; Yamazaki, Hiroshi; Takamoto, Mikihiro; Pei, Lixia; Qin, Xiang; Masterson, Tara J; Campagna, Michela; Vreys, Veronique; Lau, Bonnie W; Takamatsu, Yasushi
多发性骨髓瘤
骨髓瘤
发表日期：2026
文献求助 收藏

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)

泊马度胺环磷酰胺地塞米松与泊马度胺地塞米松单药治疗复发或难治性多发性骨髓瘤的随机3期研究：亚洲骨髓瘤网络研究（AMN003）

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01356-z
Kim, Jin Seok; Song, Yang; Jen, Wei-Ying; Chim, C S; Lee, Je-Jung; Yoon, Sung-Soo; Ng, Soo Chin; Gan, Gin Gin; Handa, Hiroshi; Lee, Jae Hoon; Kim, Kihyun; Ito, Shigeki; Huang, Jeffrey Shang-Yi; Min, Chang Ki; Ooi Gaik Ming, Melissa; de Mel, Sanjay; Soekojo, Cinnie; Li, Xinhua; Awasthi, Neha; Pokharkar, Yogesh; Durie, Brian Gm; Chng, Wee-Joo
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Radiation source detection for the accurate location of lymph node metastases using robotic forceps-type coincidence radiation detector

利用机器人钳式符合辐射探测器进行辐射源探测，以精确定位淋巴结转移灶

期刊:International Journal of Computer Assisted Radiology and Surgery
影响因子:2.3
doi:10.1007/s11548-024-03296-8
Kawamura, Kazuya; Nakajima, Ayano; Ito, Shigeki; Takahashi, Miwako; Yamaya, Taiga
发表日期：2025
文献求助 收藏

Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a Japanese expert panel

关于复发/难治性多发性骨髓瘤患者接受贝兰他单抗治疗后出现眼部不良事件的临床管理实用指南：日本专家组的建议

期刊:Japanese Journal of Clinical Oncology
影响因子:2.2
doi:10.1093/jjco/hyaf148
Sunami, Kazutaka; Fujisaki, Tomoaki; Funaki, Toshinari; Ichii, Michiko; Ito, Shigeki; Matsumoto, Morio; Oshima, Koh-Ichi; Suzuki, Kazuhito; Takakuwa, Teruhito
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM

talquetamab（一种人源化GPRC5D x CD3双特异性抗体）在日本复发/难治性多发性骨髓瘤患者中的I期研究

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-025-03991-5
Iida, Shinsuke; Sunami, Kazutaka; Ito, Shigeki; Yuda, Junichiro; Fujikawa, Ei; Takamoto, Mikihiro; Aida, Kensuke; Yamazaki, Hiroshi; Takahashi, Marimo; Ishida, Tadao
多发性骨髓瘤
CD3
骨髓瘤
发表日期：2025
文献求助 收藏

Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen

采用 R-THP-COP 方案治疗的新诊断弥漫性大 B 细胞淋巴瘤的预后预测因素

期刊:Journal of Clinical and Experimental Hematopathology
影响因子:1.4
doi:10.3960/jslrt.24073
Okano, Yoshiaki; Oyake, Tatsuo; Kitamura, Sawako; Asano, Kazuya; Sato, Tsuyoshi; Maeta, Takahiro; Miyajima, Shinri; Otsu, Akihiro; Nishiya, Maki; Sasaki, Ryousei; Kowata, Shugo; Ishida, Yoji; Ito, Shigeki
淋巴瘤
细胞生物学
T细胞
发表日期：2025
文献求助 收藏

Magnetic resonance imaging findings of intravascular large B-cell lymphoma mimicking fasciitis of the thigh: A case report

磁共振成像显示血管内大B细胞淋巴瘤酷似大腿筋膜炎：病例报告

期刊:Journal of Clinical and Experimental Hematopathology
影响因子:1.4
doi:10.3960/jslrt.24072
Suzuki, Michiko; Yashima-Abo, Akiko; Ehara, Shigeru; Ito, Shigeki; Satoh, Takashi
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Potential role of lipophagy impairment for anticancer effects of glycolysis-suppressed pancreatic ductal adenocarcinoma cells

脂肪吞噬障碍对糖酵解抑制的胰腺导管腺癌细胞抗癌作用的潜在作用

期刊:Cell Death Discovery
影响因子:6.1
doi:10.1038/s41420-024-01933-4
Zhiheng Zhang #, Haruna Aoki #, Keitaro Umezawa, Joshua Kranrod, Natsumi Miyazaki, Taichi Oshima, Takuya Hirao, Yuri Miura, John Seubert, Kousei Ito, Shigeki Aoki
免疫
细胞生物学
胰腺癌
肿瘤细胞
发表日期：2024
文献求助 收藏

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan

日本一项前瞻性、多中心、观察性研究，旨在评估伊沙佐米联合来那度胺-地塞米松治疗复发/难治性多发性骨髓瘤患者的疗效。

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-023-05428-7
Horigome, Yuichi; Iino, Masaki; Harazaki, Yoriko; Kobayashi, Takahiro; Handa, Hiroshi; Hiramatsu, Yasushi; Kuroi, Taiga; Tanimoto, Kazuki; Matsue, Kosei; Abe, Masahiro; Ishida, Tadao; Ito, Shigeki; Iwasaki, Hiromi; Kuroda, Junya; Shibayama, Hirohiko; Sunami, Kazutaka; Takamatsu, Hiroyuki; Tamura, Hideto; Hayashi, Toshiaki; Akagi, Kiwamu; Maeda, Takahiro; Yoshida, Takahiro; Mori, Ikuo; Shinozaki, Tomohiro; Iida, Shinsuke
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3

Elranatamab治疗日本复发/难治性多发性骨髓瘤患者：MagnetisMM-2和MagnetisMM-3研究结果

期刊:Japanese Journal of Clinical Oncology
影响因子:2.2
doi:10.1093/jjco/hyae068
Iida, Shinsuke; Ito, Satoshi; Yokoyama, Hisayuki; Ishida, Tadao; Nagai, Yuya; Handa, Hiroshi; Ito, Shigeki; Kamei, Yoichi; Nakamura, Masatoshi; Suzuki, Kenshi
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏